Advertisement
New Zealand markets close in 8 minutes
  • NZX 50

    11,892.14
    +88.86 (+0.75%)
     
  • NZD/USD

    0.5945
    +0.0010 (+0.17%)
     
  • NZD/EUR

    0.5550
    +0.0009 (+0.17%)
     
  • ALL ORDS

    7,946.70
    +8.80 (+0.11%)
     
  • ASX 200

    7,691.30
    +7.80 (+0.10%)
     
  • OIL

    83.45
    +0.09 (+0.11%)
     
  • GOLD

    2,341.30
    -0.80 (-0.03%)
     
  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • Hang Seng

    17,110.21
    +281.28 (+1.67%)
     
  • NIKKEI 225

    38,367.11
    +814.95 (+2.17%)
     
  • NZD/JPY

    91.9630
    +0.1970 (+0.21%)
     

Company News For Jun 18, 2018

Is (WM) Outperforming Other Business Services Stocks This Year?
  • Canada Goose Holdings Inc.’s GOOS shares surged 33.1% after the company reported fiscal fourth quarter 2018 earnings of $0.07, in contrast to the Zacks Consensus Estimate of a loss of $0.08

  • Shares of Facebook, Inc. FB declined 0.5% on news that the social media giant’s top policy strategist Elliot Schrage leaving the company

  • Dr. Reddy's Laboratories Limited’s RDY shares jumped 6.2% after the company announced that it has received the final approval from FDA for its Naloxone Sublingual Film and uprenorphine used to treat opioid dependence/addiction in adults

  • §  Shares of Twenty-First Century Fox, Inc. FOXA rose 0.2% on news that New York Yankees was contemplating buying back Fox’s stake in the Yes network if Fox completes a planned asset sale to either Comcast or Walt Disney


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Facebook, Inc. (FB) : Free Stock Analysis Report
 
Dr. Reddy's Laboratories Ltd (RDY) : Free Stock Analysis Report
 
Twenty-First Century Fox, Inc. (FOXA) : Free Stock Analysis Report
 
Canada Goose Holdings Inc. (GOOS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research